Discover
CGTX
Cognition Therapeutics, Inc.
0.70
1 x 0.65
1 x 0.78
bid
ask
-
0.04
5.57%
1 @ 04:00 PM
0.70 +0.00 (0.00%)
| Ytd | -48.28% | |
| 1y | -57.68% |
0.65
day range
0.72
0.55
52 week range
1.83
| Open | 0.72 | Prev Close | 0.74 | Low | 0.65 | High | 0.72 | Mkt Cap | 65.20M |
| Vol | 555.95K | Avg Vol | 514.64K | EPS | -0.17 | P/E | N/A | Forward P/E | -0.80 |
| Beta | 1.33 | Short Ratio | 1.07 | Inst. Own | 24.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.92 | 200-d Avg | 1.07 | 1yr Est | 6.50 |
| Income Statement | |||
| Operating Expenses | 7.74M | ||
| Research and Development Expense | 5.10M | ||
| Selling, General and Administrative Expense | 2.64M | ||
| Operating Income | -7.74M | ||
| Interest Expense | 3.00K | ||
| Net Income | -3.93M | ||
| Net Income Common Stock | -3.93M | ||
| Net Income Common Stock (USD) | -3.93M | ||
| Consolidated Income | -3.93M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -3.93M | ||
| Earning Before Interest & Taxes (USD) | -3.93M | ||
| Weighted Average Shares | 90.62M | ||
| Weighted Average Shares Diluted | 90.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 34.76M | ||
| Cash and Equivalents (USD) | 34.76M | ||
| Current Assets | 38.30M | ||
| Property, Plant & Equipment Net | 597.00K | ||
| Total Assets | 38.90M | ||
| Debt Current | 89.00K | ||
| Total Debt | 511.00K | ||
| Current Liabilities | 5.45M | ||
| Debt Non-Current | 422.00K | ||
| Total Liabilities | 5.87M | ||
| Accumulated Retained Earnings (Deficit) | -207.15M | ||
| Shareholders Equity | 33.02M | ||
| Shareholders Equity (USD) | 33.02M | ||
| Assets Non-Current | 597.00K | ||
| Total Debt (USD) | 511.00K | ||
| Deferred Revenue | 777.00K | ||
| Liabilities Non-Current | 422.00K | ||
| Trade and Non-Trade Payables | 673.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 55.00K | ||
| Net Cash Flow from Financing | 6.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.54M | ||
| Capital Expenditure | -20.00K | ||
| Issuance (Purchase) of Equity Shares | 6.74M | ||
| Issuance (Repayment) of Debt Securities | -116.00K | ||
| Net Cash Flow from Investing | -20.00K | ||
| Net Cash Flow from Operations | -3.05M | ||
| Share Based Compensation | 319.00K | ||